Discussion
albuminuria, microalbuminuria, diabetic nephropathy, diabetic kidney disease
DIABETIC NEPHROPATHY, DIABETIC KIDNEY DISEASE
In this This There are various discussions in the literature about microalbuminuria changes as a surrogate endpoint of diabetic kidney disease [There are several methodologies that can directly handle multiple and/or time-dependent mediators [The current analysis has several limitations. This was a In conclusion, esaxerenone has a UACR-lowering effect beyond lowering BP and thus can be a treatment option for diabetic nephropathy in patients with albuminuria.